Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations

PLoS Genetics

Volumn 3, Issue 6, 2007, Pages 1108-1119

  Spierings, Eric ^a   Hendriks, Matthijs ^a   Absi, Léna ^b   Canossi, Angelica ^c   Chhaya, Sonal ^d   Crowley, John ^e   Dolstra, Harry ^f   Eliaou, Jean François ^g   Ellis, Tom ^h   Enczmann, Jürgen ⁱ   Fasano, Maria E ^j   Gervais, Thibaut ^k   Gorodezky, Clara ^l   Kircher, Brigitte ^m   Laurin, David ⁿ   Leffell, Mary S ^o   Loiseau, Pascale ^p   Malkki, Mari ^q   Markiewicz, Miroslaw ^r   Martinetti, Miryam ^s   Maruya, Etsuko ^t   Mehra, Narinder ^u   Oguz, Fatma ^v   Oudshoorn, Machteld ^a,w   Pereira, Noemi ^x   Rani, Rajni ^y   Sergeant, Ruhena ^z   Thomson, Jackie ^aa   Thuong, Hien Tran ^ab   Turpeinen, Hannu ^ac   Yang, Kuo Liang ^ad   Zunec, Renata ^ae   Carrington, Mary ^af,ag   De Knijff, Peter ^a   Goulmy, Els ^a   more..

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Istituto CNR Trapianti d'Organo e l'Immunocitologia   (Italy)

^d TATA MEMORIAL HOSPITAL   (India)

^e National Blood Centre Ireland   (Ireland)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g HÔPITAL SAINT ELOI   (France)

^h BLOOD RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^j MOLINETTE HOSPITAL   (Italy)

^k CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^l Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^m INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁿ Laboratoire d'Immunologie   (France)

^o JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p SAINT LOUIS HOSPITAL   (France)

^q Fred Hutchinson Cancer Research Center   (United States)

^r MEDICAL UNIVERSITY OF SILESIA   (Poland)

^s FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^t Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^u ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^v ISTANBUL UNIVERSITY   (Turkey)

^w Europdonor Foundation   (Netherlands)

^x FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^y NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^z HAMMERSMITH HOSPITAL   (United Kingdom)

^aa UNIVERSITY OF CAPE TOWN   (South Africa)

^ab UNIVERSITY OF HEIDELBERG   (Germany)

^ac FINNISH RED CROSS BLOOD SERVICE   (Finland)

^ad BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^ae KBC Zagreb   (Croatia)

^af SAIC FREDERICK INC   (United States)

^ag NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MINOR HISTOCOMPATIBILITY ACC 1; MINOR HISTOCOMPATIBILITY ACC 2; MINOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN 1; MINOR HISTOCOMPATIBILITY ANTIGEN 2; MINOR HISTOCOMPATIBILITY ANTIGEN 3; MINOR HISTOCOMPATIBILITY ANTIGEN 8; MINOR HISTOCOMPATIBILITY HB 1; MINOR HISTOCOMPATIBILITY PANE1; MINOR HISTOCOMPATIBILITY SP110; MINOR HISTOCOMPATIBILITY UGT2B17; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ANALYSIS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNOTHERAPY; ORGAN; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; COMPARATIVE STUDY; FEMALE; GENETICS; IMMUNOPHENOTYPING; MULTICENTER STUDY; POPULATION GENETICS; RACE;

CONTINENTAL POPULATION GROUPS; FEMALE; GENE FREQUENCY; GENETICS, POPULATION; HUMANS; IMMUNOPHENOTYPING; MINOR HISTOCOMPATIBILITY ANTIGENS;

EID: 34347363145     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0030103     Document Type: Article

References (38)

1. Simpson E, Roopenian D, Goulmy E (1998) Much ado about minor histocompatibility antigens. Immunol Today 19: 108-112.
2. Spierings E, Goulmy E (2005) Expanding the immunotherapeutic potential of minor histocompatibility antigens. J Clin Invest 115: 3397-3400.
3. Goulmy E (1996) Human minor histocompatibility antigens. Curr Opin Immunol 8: 75-81.
4. Goulmy E, Persijn G, Blokland E, D'Amaro J, van Rood JJ (1981) Cell-mediated lympholysis studies in renal allograft recipients. Transplantation 31: 210-217.
5. Spierings E, Wieles B, Goulmy E (2004) Minor histocompatibility antigens-big in tumour therapy. Trends Immunol 25: 56-60.
6. Goulmy E (2006) Minor histocompatibility antigens: from transplantation problems to therapy of cancer. Hum Immunol 67: 433-438.
7. de Bueger MM, Bakker A, van Rood JJ, van der Woude F, Goulmy E (1992) Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 149: 1788-1794.
8. Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, et al. (2002) In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 8: 410-414.
9. Klein CA, Wilke M, Pool J, Vermeulen C, Blokland E, et al. (2002) The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. J Exp Med 196: 359-368.
10. Fujii N, Hiraki A, Ikeda K, Ohmura Y, Nozaki I, et al. (2002) Expression of minor histocompatibility antigen, HA-1, in solid tumor cells. Transplantation 73: 1137-1141.
11. Choi SS, Park IC, Yun JW, Sung YC, Hong SI, et al. (1995) A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693-1698.
12. Slager EH, Honders MW, van der Meijden ED, Luxemburg-Heijs SA, Kloosterboer FM, et al. (2006) Identification of the angiogenic endothelial cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer. Blood 107: 4954-4960.
13. van der Harst D, Goulmy E, Falkenburg JH, Kooij-Winkelaar YM, Luxemburg-Heijs SA, et al. (1994) Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 83: 1060-1066.
14. Falkenburg JH, Goselink HM, van der Harst D., Luxemburg-Heijs SA, Kooy-Winkelaar YM, et al. (1991) Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Exp Med 174: 27-33.
15. Hambach L, Nijmeijer BA, Aghai Z, Schie ML, Wauben MH, et al. (2006) Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice. Leukemia 20: 371-374.
16. Kircher B, Stevanovic S, Urbanek M, Mitterschiffthaler A, Rammensee HG, et al. (2002) Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion. Br J Haematol 117: 935-939.
17. Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, et al. (2003) Hematopoiesis-restricted minor histocompatibility antigens HA-1-or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci U S A 100: 2742-2747.
18. Goulmy E (1985) Class-I-restricted human cytotoxic T lymphocytes directed against minor transplantation antigens and their possible role in organ transplantation. Prog Allergy 36: 44-72.
19. Cai J, Lee J, Jankowska-Gan E, Derks R, Pool J, et al. (2004) Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 199: 1017-1023.
20. Verdijk RM, Kloosterman A, Pool J, van de Keur M, Naipal AM, et al. (2004) Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: Implications for stem cell transplantation and immunotherapy. Blood 103: 1961-1964.
21. Mommaas B, Stegehuis-Kamp JA, van Halteren AG, Kester M, Enczmann J, et al. (2004) Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 105: 1823-1827.
22. Pietz BC, Warden MB, Duchateau BK, Ellis TM (2005) Multiplex genotyping of human minor histocompatibility antigens. Hum Immunol 66: 1174-1182.
23. The International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789-796.
24. Dolstra H, de Rijke B, Fredrix H, Balas A, Maas F, et al. (2002) Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. Eur J Immunol 32: 2748-2758.
25. Akatsuka Y, Warren EH, Gooley TA, Brickner AG, Lin MT, et al. (2003) Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling. Br J Haematol 123: 671-675.
26. Akatsuka Y, Nishida T, Kondo E, Miyazaki M, Taji H, et al. (2003) Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 197: 1489-1500.
27. Seldin MF, Shigeta R, Villoslada P, Selmi C, Tuomilehto J, et al. (2006) European population substructure: Clustering of northern and southern populations. PLoS Genet 2: e143. doi:10.1371/journal.pgen.0020143
28. Di Terlizzi S, Zino E, Mazzi B, Magnani C, Tresoldi C, et al. (2006) Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations. Biol Blood Marrow Transplant 12: 95-101.
29. Spierings E, Brickner AG, Caldwell JA, Zegveld S, Tatsis N, et al. (2003) The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 102: 621-629.
30. Brickner AG, Warren EH, Caldwell JA, Akatsuka Y, Golovina TN, et al. (2001) The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 193: 195-206.
31. Murata M, Warren EH, Riddell SR (2003) A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion. J Exp Med 197: 1279-1289.
32. de Rijke B, van Horssens-Zoetbrood A, Beekman JM, Otterrud B, Maas F, et al. (2005) A frame-shift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J Clin Invest 115: 3506-3516.
33. Brickner AG, Evans AM, Mito JK, Xuereb SM, Feng X, et al. (2006) The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 107: 3779-3786.
34. Mommaas B, Kamp J, Drijfhout JW, Beekman N, Ossendorp F, et al. (2002) Identification of a Novel HLA-B60-Restricted T Cell Epitope of the Minor Histocompatibility Antigen HA-1 Locus. J Immunol 169: 3131-3136.
35. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
36. Parker KC, Bednarek MA, Coligan JE (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152: 163-175.
37. Spierings E, Drabbels J, Hendriks M, Pool J, Spruyt-Gerritse M, et al. (2006) A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS ONE 1: e42. doi:10.1371/journal.pone.0000042
38. Delfiner P (1976) Linear estimation of non-stationary spatial phenomena. In: Guarascio M, et al., editors. Advanced geostatistics for the mining industry, Proceedings of NATO ASI. Dordrecht (The Netherlands): Reidel Publishing Company. pp. 49-68.